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Abstract
To reduce costs of lipid-binding assays, allow for multiple lipids to be screened for protein binding 
simultaneously, and to make lipid binding more user friendly, lipids have been dotted onto 
membranes to investigate lipid-protein interactions. These assays are similar to a western blot 
where the membrane is blocked, incubated with a protein of interest and detected using antibodies. 
Although the assay is inexpensive and straightforward, problems with promiscuous or poor 
binding, as well as insufficient blocking occur frequently. In this technical note, we share several 
specific improvements to ensure lipid-protein overlay assays are of high quality and contain proper 
controls.
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Introduction
For almost 20 years different variations of lipids blotted onto a hydrophobic membrane, 
including what are commonly known as PIP Strips, have been employed as a method to 
investigate protein-lipid interactions [1]. Their purpose has ranged from screening a new 
protein for its lipid binding selectivity, to testing protein specificity for phosphoinositides or 
sphingolipids.
PIP Strips are commercially sold with 15 different lipids dotted onto a cellulose blotting 
membrane containing 100 pmol of lipid per spot (figure 1A). PIP Strips have been 
advantageous for several reasons: the assay is time efficient, cost effective, and requires very 
little protein (less than 0.5 μg/ml). Up to 15 lipids can be screened in one day at little cost 
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compared to other more laborious and expensive assays (e.g., fluorescence, FRET, 
centrifugation, or surface plasmon resonance) used to investigate lipid-protein interactions. 
Unfortunately, PIP Strips can sometimes show promiscuous or poor lipid binding [2,3], and 
often show insufficient blocking techniques in published figures [3,4]. Therefore, it is 
common for PIP Strips to be used as a secondary method for investigating protein-lipid 
binding. For example, ELISA assays [5] and Surface Plasmon Resonance (SPR) [6, 7] are 
techniques commonly used to verify protein-lipid interactions, as they can test binding 
specificity and determine binding coefficients in a more physiological setting.
The procedure for PIP Strips is relatively straightforward and shows similarities to a western 
blot; the PIP Strip membrane is blocked with TBS-T + 3% BSA, incubated with a purified 
protein of interest, and then detected using primary and secondary antibodies (figure 1B). 
PIP Strips can test specificity of lipid antibodies; test affinity tag purified proteins for either 
their specificity or their overall lipid-binding properties (figure 2). The goal of this technical 
paper is to provide helpful tips for washing and incubating the blot with proteins/antibodies, 
setting up controls, and detecting the blot to ultimately aid users of PIP Strips in obtaining 
clean, unsaturated, and publication quality blots.
Materials
PIP Strips (P-6001), Anti-PI(3)P IgG (Z-P003), and Anti-PI(4)P IgM (Z-P004) were 
purchased from Echelon Biosciences (Salt Lake City, UT). Western Blot incubation box was 
purchased from Li-Cor (Lincoln, NE), ECL Plus Western Blotting Substrate (#32132) was 
purchased from Pierce (Rockford, IL), and PI(4)P (850151) was purchased from Avanti 
Polar Lipids (Alabaster, AL). Goat Anti-Mouse IgG HRP (#170-6516) and Goat Anti-Rabbit 
HRP (#170-5046) were purchased from Bio-Rad (Hercules, CA), Anti-GST (ab19256) and 
Rb Anti-6xHis (ab137839) were purchased from Abcam (United Kingdom). Goat Anti-
Mouse IgG HRP (sc-2005) was purchased from Santa Cruz (Santa Cruz, CA). Fatty Acid 
Free BSA (A7030) was purchased from Sigma-Aldrich (St. Louis, MO).
Protocol
Handling of PIP Strips
PIP Strips should be stored at 4°C, void of light. The Hybond cellulose membranes are 
separated by wax-like paper within the packaging. When using a new strip, caution should 
be taken to use methanol-cleansed tweezers. Only use the tweezers on the edge or corners of 
the PIP Strip or wax paper when moving the blot from packaging to the incubation box. This 
prevents non-specific dark spots on the blot during development (see also figure 4b). The 
correct orientation of the PIP strip should have the diagonal cut on the top left corner and the 
blue control dot on the bottom right. The PIP Strip fits well in western blotting boxes with 
dimensions of 5×7 cm. If using those boxes, 5 ml of solution is sufficient for all steps. An 
increase or decrease in the volume depending on the size of the box should also be taken 
into account.
Shirey et al. Page 2
Anal Biochem. Author manuscript; available in PMC 2018 January 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Controls
Several control experiments are recommended. First, we recommend a “no primary 
antibody” and “no secondary antibody” control. This will rule out any nonspecific binding 
of primary or secondary antibodies to various lipids on the membranes. Second, we 
recommend putting a positive control on the PIP Strip by “dotting” a control lipid or protein 
on to the membrane. It is recommended that a protein with well-established lipid specificity 
be used as a positive control. This can also be used to detect any nonspecific lipid 
interactions on commercial strips. Two separate controls are recommended: 1) dotting the 
PIP strip with the control protein (e.g., Lact-C2) in order to confirm detection of protein with 
primary and secondary antibody and dotting the lipid (e.g., PS for Lact-C2) that the control 
protein binds to in order to ensure specific lipid binding detection. The control protein of 
interest or lipid to be detected should be dotted onto the PIP Strip prior to blocking. For 
example Lact-C2 can be used for PS, SidM for PI(4)P, p40phox PX domain for PI(3)P, or the 
PLCδ PH domain for PI(4,5)P2 as appropriate positive controls (Table 1). To do this, leave 
the wax paper under the membrane, then dot the membrane with lipid or protein in a spot 
that will not interfere with the pre-dotted lipids; the top middle portion of the blot is usually 
a good place for this (Figure 1A). Since 100 pmol of lipid is dotted onto the membrane by 
the manufacturer, aim to dot a similar amount of lipid or protein in a volume of ~0.5–1.0 μl 
onto the membrane. The protein/lipid can be dotted in its stock solution, as long as ample 
time is allowed for the spot to dry. For example, lipids dissolved in chloroform will dry 
much quicker (~5 minutes) compared to aqueous buffers (~15 minutes). After the dot has 
dried, carefully separate the wax paper and membrane, and place the membrane in the 
incubation box and proceed with blocking the membrane.
Blocking
Add 5 ml TBS-T* + 3% BSA to the blot. Let the blocking buffer incubate with the blot for 1 
hour at room temperature or overnight at 4°C. All steps should be performed with gentle 
shaking ~100 rpm. The Echelon PIP Strip protocol claims to use alternative blocking 
buffers, such as TBS + 0.1% ovalbumin, TBS + 1% non-fat dry milk, or PBS rather than 
TBS, if background noise becomes a problem. * TBS-T: 10 mM Tris, pH 8.0, 150 mM 
NaCl, 0.1 % (v/v) Tween20.
Protein Incubation
After decanting off the blocking buffer, incubate the blot with the purified protein of interest. 
Echelon recommends starting with 0.5 μg/ml, but it is recommended to try lower protein 
concentrations if possible to avoid saturation of the binding signal. Dilute the protein in 5 ml 
of TBS-T + 3% BSA, or enough volume to cover the membrane. Incubate the protein for 2 
hours at room temperature or overnight at 4°C. If the protein is prone to degradation, do not 
incubate overnight.
Washing
In order to minimize the effect of smearing or oversaturation, decant the blocking buffer 
from the box into a waste beaker (Figure 3). Do this by tipping the incubation box into the 
waste beaker and touching the corner of the box to the edge of the beaker. The blot will stick 
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to the bottom of the box during this process. Do this step carefully, but quickly, to avoid 
drying out the blot. After decanting, add 5 ml TBS-T to the box and incubate for 10 minutes 
at room temperature with gentle shaking. Repeat the wash step a total of 3 times. Always 
decant solution as described above when changing solutions; avoid using tweezers to hold 
the PIP strips, and avoid moving the blot from one box to another.
Incubate with Primary Antibody
Detect the protein of interest with a primary antibody. For example, Anti-GST antibody can 
be used against a GST-tagged protein. Alternatively, Anti-GST HRP-conjugated antibodies 
can be used in this step. This would skip the incubation step with a secondary antibody. 
Dilute the appropriate antibody in TBS-T + 3% BSA. Use recommended dilution from 
manufacturer; using the recommended dilution for western blots is comparable to the 
dilution needed for PIP Strips. Prepare antibody dilution prior to the last wash step to ensure 
quick decanting of wash buffer and addition of antibody solution. Incubate blot for 1 hour at 
room temperature with gentle shaking.
Washing
Wash the membrane as previously described under, “Washing.”
Incubate with Secondary Antibody
Prepare HRP conjugated antibody in TBS-T + 3% BSA. Decant the wash solution and add 
the secondary antibody. Incubate this solution with the PIP Strip for 1 hour at room 
temperature with gentle shaking.
Washing
Wash the membrane as previously described under, “Washing.”
Detect
Discard the wash solution and detect the bound protein with a method appropriate with your 
experiment. For HRP conjugated antibodies, use ECL substrate with chemiluminescent 
detection. ECL detection only requires 1–2 ml of solution (enough to cover the PIP Strip). 
Let the ECL reagent sit for ~ 1 minute (times may vary), and then use chemiluminescent 
detection.
Results and Discussion
Using the methods described here, we show three examples of how PIP Strips can be used to 
investigate protein-lipid interactions. First we use the Anti-PI(4)P antibody to show its 
specificity to only the PI(4)P lipid, as expected (Figure 2A). We also demonstrate how using 
varying dilutions of this antibody affect the signal produced, as optimization is necessary for 
these experiments.
Additionally we show how to test the lipid specificity of affinity tag purified proteins using 
GST-SidM, a PI(4)P-specific binding protein [8]. The PIP Strip was blocked, incubated with 
GST-SidM and then an Anti-GST HRP-conjugated antibody. In this case using a primary 
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antibody that is HRP conjugated eliminates the use of a secondary antibody. The results 
show strong binding to the PI(4)P lipid, as well as the control PI(4)P lipid that was dotted 
onto the membrane prior to blocking.
Another use of PIP Strips is screening a protein for its lipid-binding characteristics. We used 
a purified 6xHis-tagged PKCα C2 domain protein to investigate its lipid binding 
characteristics. The PIP Strip was blocked, incubated with 6x-His PKCα C2, then with 
rabbit anti-6xHis antibody, and finally with a goat anti-rabbit antibody with HRP conjugate. 
These results revealed binding to several different lipids including phosphatidylserine and 
phosphoinositides as previously reported [9,10]. Researchers can use this blot as a starting 
point to further investigate lipid-binding properties or compare binding to published 
literature. However, caution needs to be taken. In this instance, PKCα C2 is well established 
to bind PS containing membranes with nanomolar affinity [9,10] and also binds to PI(4,5)P2 
[10], an important interaction for its cellular localization [10]. While other phosphoinositide 
binding has been detected for the PKCα C2 domain [10], the results to do not support much 
of the published literature on this lipid binding interaction. The PKCα C2 domain anionic 
lipid binding is also calcium-dependent, which may also lead to different binding selectivity 
on the flat nitrocellulose surface with only one anionic lipid spotted densely within each 
circle. Thus, secondary lipid binding assays are essential to carefully dissect lipid-binding 
selectivity of proteins such as this calcium-dependent C2 domain.
Overall, using the techniques outlined above should help avoid some common errors made 
by the researcher. In Figure 4A we see how choosing a proper secondary antibody is 
important. Figure 4A blots 1 and 2 are from the same experiment, but with different 
secondary antibodies. Blot 1 is very clean while blot 2 shows significant background 
binding. Figure 4B demonstrates how touching the blot with tweezers between washes and 
incubations can negatively impact the final image with large dark spots appearing. Binding 
to lipids in that region of the blot could be unidentifiable and not quantifiable. Figure 4C 
shows the affect of using too much protein in the binding assay. In two separate experiments 
0.6 μg/ml was compared against 6 μg/ml GST-p40phox, a PI(3)P-specific binding protein. 
Oversaturation of the blot with too much protein shows non-specific binding can occur to 
other phosphoinositides, which is not likely to be physiologically relevant.
In conclusion, PIP Strips are a time efficient (4.5 to 6 hours) and cost effective assay (~
$60/per experiment) if used properly. However, secondary assays are still highly 
recommended to verify lipid-protein binding specific and to estimate affinity. The specific 
steps within this protocol are aimed at creating sensitive, reproducible, and high quality 
blots.
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Figure 1. PIP strip diagram and flow chart
A) This is the correct orientation of the PIP Strip; the top left corner has a diagonal cut. The 
optional control spot should be placed at the top in the middle. B) A flow chart of the 
experimental procedure. Two paths can be taken depending on whether the primary antibody 
or secondary antibody contains the HRP conjugate.
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Figure 2. PIP strip examples of lipid specificity
A) The Anti-PI(4)P antibody used at several dilutions (1:2000, 1:2500, and 1:3000) to show 
its binding to the PI(4)P lipid, as well as the control spot (PI(4)P lipid). B) Purified GST-
SidM protein incubated at 0.5 μg/ml and exhibits specific binding to PI(4)P. The primary 
antibody was Anti-GST with HRP-conjugate, followed by chemiluminescent detection with 
ECL reagent. C) Purified 6xHis tagged PKCα C2 domain incubated at 0.5 μg/ml. The 
primary antibody was Anti-6xHis and the secondary antibody was anti-rabbit HRP-
conjugate.
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Figure 3. Proper decanting technique
The solution is poured from the incubation box into a beaker while the corner of the box 
makes contact with the lip of the beaker (arrow). The PIP Strips stay in the bottom of the 
box without using tweezers to keep it in place. This should be performed quickly but 
carefully without allowing the blot to dry out. The next solution should be added 
immediately after decanting.
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Figure 4. Improved quality of blotting assays
A) Choosing quality primary and secondary antibodies can affect a blot’s background noise. 
Blots 1 and 2 were performed at the same time and conditions with the exception of the 
secondary antibody. It is important to check the quality and expiration of antibodies. B) 
When a blot is handled frequently between washes and incubations it can create large dark 
spots during detection that will hinder the ability to determine what lipid(s) the protein binds 
to. C) Oversaturating the blot with protein can create non-specific binding. It is important to 
test lower concentrations of protein as high protein concentrations can lead to a higher 
incidence of nonspecific binding. 0.6 μg/ml is compared against 6 μg/ml GST-p40phox. + 
indicates a positive control.
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Table 1
Recommended control proteins for different lipid binding specificities.
Lipid Control Protein
PI(3)P p40phox PX domain
PI(4)P SidM
PS Lactadherin C2 domain
PI(4,5)P2 PLCδ PH domain
PI(3,4,5)P3 Akt1 PH domain
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